Here the authors show instead that fenamate NSAIDs inhibit the Nlrp3 inflammasome via an effect on volume-regulated anion channel function and also repurpose these drugs for therapeutic effect in rodent models of Alzheimer disease. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.